Search results

Skip to results

Area of interest

Type

Status

Last updated

Showing 2221 to 2235 of 7962 results

  1. Cobolimab with dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy [ID6398]

    In development [GID-TA11500] Expected publication date: TBC

  2. Acalabrutinib for treating relapsed or refractory mantle cell lymphoma [ID6389]

    Awaiting development [GID-TA11470] Expected publication date: TBC

  3. Vepdegestrant for treating hormone receptor-positive HER2-negative metastatic breast cancer after endocrine treatment [ID6360]

    In development [GID-TA11400] Expected publication date: TBC

  4. Pembrolizumab with chemotherapy for treating platinum-resistant recurrent ovarian cancer after 1 or 2 treatments [ID6363]

    In development [GID-TA11422] Expected publication date: TBC

  5. Lacosamide for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [ID1687]

    In development [GID-TA10664] Expected publication date: TBC

  6. DOASENSE DOAC dipstick product for the detection of direct oral anti-coagulants

      Status ...

  7. CytoSorb for reducing risk of bleeding during cardiac surgery

      Status ...

  8. Moor LDLS-BI for assessing burn depth and healing potential in children and adults

      Status ...

  9. The Stak for knee stretching following knee replacement or injury or to treat osteoarthritis

      Status ...

  10. URO17 for testing suspected bladder cancer

      Status ...

  11. RenalSense Clarity RMS for acute kidney injury MT601 (MIB256)

      Status ...

  12. Syne Covid for predicting COVID-19 outcomes MT655

      Status ...

  13. Kodex EPD system MT575 (MIB260)

      Status ...

  14. MTEP - Routing Butterfly IQ ultrasound scanner MT635 (MIB254)

      Status ...

  15. PROPEL (mometasone furoate implant, 370ug) MT578 (MIB253)

      Status ...